Metraipolis › archive › dc_04651af51e4b

Evaluation of the Accuracy of Asprosin as a Biomarker in Breast Cancer — Europe PMC PMID:41898145

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41898145
DOI
10.3390/biomedicines14030498
License (as archived)
solo-consultazione
Archived
2026-11-05T08:04:44.798Z
SHA-256 of the archived text
00421c3a5caca6ab3fb67b587125cc1115f22906f2fe1a1072b26b26b37cba73
Stable URL of this page
https://metraipolis.com/documento/dc_04651af51e4b

How to cite

Evaluation of the Accuracy of Asprosin as a Biomarker in Breast Cancer — Europe PMC PMID:41898145 — Europe PMC (en), https://europepmc.org/article/MED/41898145 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04651af51e4b (Metraipolis archive dc_04651af51e4b, sha256 00421c3a5caca6ab3fb67b587125cc1115f22906f2fe1a1072b26b26b37cba73)
BibTeX
@misc{dc04651af51e4b,
  title = {Evaluation of the Accuracy of Asprosin as a Biomarker in Breast Cancer — Europe PMC PMID:41898145},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41898145},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04651af51e4b; sha256 00421c3a5caca6ab3fb67b587125cc1115f22906f2fe1a1072b26b26b37cba73},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898145. Agents can read the archived copy with the MCP tool read_document.